At the Global Health Exhibition in Riyadh, GoldTrack Ventures announced the launch of a USD 250 million industrial biotechnology growth fund, marking a major milestone for Saudi Arabia’s growing life sciences and innovation ecosystem. The fund is designed to scale biotech enterprises locally and globally, while advancing sustainable industrial transformation.
Driving Industrial Biotechnology Growth
GoldTrack Ventures plans to structure the fund and file it with the Capital Market Authority (CMA) by the end of 2025. The first round of investments is expected in 2026, targeting high-impact biotech startups and projects.
The fund’s core mission is to:
- Boost Saudi Arabia’s biotechnology sector and align it with national industrial priorities.
- Support innovation-driven companies across the Middle East and beyond.
- Encourage cross-sector partnerships that bridge science, industry, and capital.
Mark Rayner, Managing Partner at GoldTrack Ventures, said, “Along with the rapid growth of digital ecosystems, we are building vibrant industrial ecosystems that will redefine how industries grow, produce, and thrive sustainably.”
A Multi-Sector Focus for a Sustainable Future
The new fund will invest across multiple branches of biotechnology, covering:
- Red biotech for healthcare and pharmaceuticals.
- Green biotech for agriculture and environmental solutions.
- White biotech for industrial production and bio-based materials.
- Yellow, grey, blue, and golden biotech for energy, waste management, marine science, and bioinformatics.
The focus will remain on industrial applications, agri-tech, and sustainable production technologies that help reduce environmental impact while promoting economic resilience.
This multi-sector approach reflects the growing role of biotechnology in achieving Vision 2030 goals, especially in building sustainable, knowledge-based industries.
Connecting Science, Capital, and Industry
GoldTrack Ventures plans to leverage its global experience in fund management and deep regional partnerships to accelerate biotech commercialization. Its strategy includes working closely with:
- Academic research institutions to translate scientific discoveries into market-ready solutions.
- Industrial partners to integrate biotech innovations into large-scale production.
- Local investors and entrepreneurs to strengthen the region’s innovation pipeline.
The fund will also support companies seeking to scale internationally, giving Saudi-based startups access to global networks, expertise, and investment opportunities.
GoldTrack Ventures GmbH, based in Europe, has a proven record in biotech investment and sustainable industrial innovation. Its team brings together scientists, venture capitalists, and industry leaders with a shared goal — to connect science, capital, and partnerships that redefine how industries operate.
A Catalyst for Biotech and Sustainability in Saudi Arabia
The launch of this fund underscores Saudi Arabia’s ambition to lead industrial biotechnology across the MENA region. By investing in local innovation and global partnerships, GoldTrack Ventures is positioning the Kingdom as a biotech hub for the future, driving progress in health, agriculture, and sustainability.